Evaluating Biopharma

Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection

September 13, 2022 Evaluating Biopharma Season 1 Episode 1
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection
Evaluating Biopharma
More Info
Evaluating Biopharma
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection
Sep 13, 2022 Season 1 Episode 1
Evaluating Biopharma

In the inaugural episode of Evaluating Biopharma podcast, CPI’s Simon Hawdon speaks with Moderator John Bonham-Carter about the benefits of converting from batch to continuous processing and the critical decisions involved in making a high-quality product. Hawdon talks about whether there is an optimal time for process conversion, key equipment features that facilitate automation, and why improved sensors are imperative for process development. Finally, Hawdon shares his predictions on when he thinks real-time release sensors will debut and why necessity will always drive industry growth.  

Links from this episode:  
Evaluating Biopharma
Centre for Process Innovation 
Erbi Biosystems 

  

Evaluating Biopharma boiler: Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.

Show Notes

In the inaugural episode of Evaluating Biopharma podcast, CPI’s Simon Hawdon speaks with Moderator John Bonham-Carter about the benefits of converting from batch to continuous processing and the critical decisions involved in making a high-quality product. Hawdon talks about whether there is an optimal time for process conversion, key equipment features that facilitate automation, and why improved sensors are imperative for process development. Finally, Hawdon shares his predictions on when he thinks real-time release sensors will debut and why necessity will always drive industry growth.  

Links from this episode:  
Evaluating Biopharma
Centre for Process Innovation 
Erbi Biosystems 

  

Evaluating Biopharma boiler: Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.